Cilomilast Modulates Rhinovirus-Induced Airway Epithelial ICAM-1 Expression and IL-6, CXCL8 and CCL5 Production
Jie Zhu, Michael R Edwards, Simon D Message, Luminita A Stanciu, Sebastian L Johnston, Peter K Jeffery, Nektarios Barabutis · 2024
Read Cilomilast Modulates Rhinovirus-Induced Airway Epithelial ICAM-1 Expression and IL-6, CXCL8 and CCL5 Production by Jie Zhu, Michael R Edwards, Simon D Message, Luminita A Stanciu, Sebastian L Johnston, Peter K Jeffery, Nektarios Barabutis (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11597196.txt.
Description
The common cold virus tricks airway cells into wearing a docking tag that also calls in swelling. Jie Zhu and co-authors tested a lung drug on that play in 2024, in dishes of airway cells dosed with the virus. The drug, cilomilast, blocks an enzyme that eats a calming cell signal. A steroid served as the yardstick cure.
The drug cut the docking tag's show by more than half. One swelling call fell by two-fifths, but another rose by up to four-fifths, a split result. A third call leaned down without a firm mark. The team read the mixed bag as a clue to how the drug helps lungs in real care: less docking for germs and white cells, at the price of one raised call. The catalog adds a name the head byline lacks.
Catalog record
| CREATOR | Jie Zhu, Michael R Edwards, Simon D Message, Luminita A Stanciu, Sebastian L Johnston, Peter K Jeffery, Nektarios Barabutis |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |